According to the ”Global Endometriosis Market 2014-2018”
report Endometriosis is a common female health condition where the
endometrial tissue, which is usually found inside the lining of the
uterus, appear and grows outside the uterine cavity. Endometriosis
mostly occurs in the fallopian tubes, ovaries, outer surface of the
uterus, pelvic cavity, vagina, cervix, and bladder. Endometriosis has
rarely been reported in more distant parts of the body such as the
lungs, brain, and skin. The most common symptoms associated with
endometriosis are pelvic pain, dysmenorrhea, excessive bleeding, and
lower abdominal pain. Some of the uncommon symptoms of endometriosis are
rectal bleeding and hematuria. The detection of endometriosis in women
is difficult because of the common symptoms associated with it.
Endometriosis can be diagnosed by laparoscopy, ultrasound, pelvic exam,
and biopsy of the inner lining of the uterus. In a biopsy, the tissues
from the inner lining of the uterus of the patient are taken and tested
using the biomarkers for the presence of endometriosis. Endometriosis is
an incurable disease and relapses after the primary treatment.
Currently, the treatment options for endometriosis include the usage of
hormone therapy and analgesics to control the disease.
Analysts forecast the Global Endometriosis market will grow at a CAGR of 2.86 percent over the period 2013-2018.
Covered in this Report
This
report covers the present scenario and the growth prospects of the
Global Endometriosis market for the period 2013-2018. To calculate the
market size, the report considers the revenue generated from the sales
of various drugs used in the treatment of endometriosis that are
available in the market.
Global Endometriosis Market 2014-2018,
has been prepared based on an in-depth market analysis with inputs from
industry experts. The report covers the Americas, EMEA, and APAC
regions; it also covers the Global Endometriosis market landscape and
its growth prospects in the coming years. The report also includes a
discussion of the key vendors operating in this market.
Key Vendors
• Abbvie Inc.
• AstraZeneca plc
• Bayer AG
• Pfizer Inc.
Other Prominent Vendors
• Astellas Pharma Inc.
• Abbvie Inc.
• Repros Therapeutics Inc.
• Sanofi SA
• Takeda Pharmaceuticals Co. Ltd.
